EPIZYME

epizyme-logo

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
#People #Financial #Event #Website #More

EPIZYME

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biopharma Biotechnology Health Care

Founded:
2007-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.epizyme.com

Total Employee:
101+

Status:
Active

Contact:
1(617)349-0707

Email Addresses:
[email protected]

Total Funding:
834.08 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics



Current Advisors List

sara-nayeem_image

Sara Nayeem Board Observer @ Epizyme
Board_observer

tyler-jacks_image

Tyler Jacks Member of the Consultant Scientific Advisory Board @ Epizyme
Advisor
2007-01-01

richard-pops_image

Richard Pops Member of the Board of Directors @ Epizyme
Board_member

beth-seidenberg_image

Beth Seidenberg Member of the Board of Directors @ Epizyme
Board_member

thomas-daniel_image

Thomas Daniel Board Member @ Epizyme
Board_member
2012-05-01

kevin-conroy_image

Kevin Conroy Board Member @ Epizyme
Board_member

victoria-richon_image

Victoria Richon Board Member @ Epizyme
Board_member

grant-bogle_image

Grant Bogle Member Board Of Directors @ Epizyme
Board_member
2019-01-01

Current Employees Featured

robert-horvitz_image

Robert Horvitz
Robert Horvitz Scientific Co-Founder @ Epizyme
Scientific Co-Founder

jeffery-kutok_image

Jeffery Kutok
Jeffery Kutok Chief Scientific Officer @ Epizyme
Chief Scientific Officer
2020-04-01

yi-zhang_image

Yi Zhang
Yi Zhang Scientific Co-Founder @ Epizyme
Scientific Co-Founder

grant-bogle_image

Grant Bogle
Grant Bogle President & Chief Executive Officer @ Epizyme
President & Chief Executive Officer
2021-08-01

mark-de-rosch_image

Mark De Rosch
Mark De Rosch Chief Regulatory Officer @ Epizyme
Chief Regulatory Officer
2019-09-01

john-weidenbruch_image

John Weidenbruch
John Weidenbruch General Counsel @ Epizyme
General Counsel
2017-08-01

tanja-weber_image

Tanja Weber
Tanja Weber SVP, Business Development & Alliance Management @ Epizyme
SVP, Business Development & Alliance Management
2019-05-01

john-bishop_image

John Bishop
John Bishop SVP, Pharmaceutical Sciences @ Epizyme
SVP, Pharmaceutical Sciences
2017-05-01

jerald-korn_image

Jerald Korn
Jerald Korn Chief Operating Officer @ Epizyme
Chief Operating Officer
2022-03-01

erin-boyer_image

Erin Boyer
Erin Boyer Chief People & Culture Officer @ Epizyme
Chief People & Culture Officer
2020-11-01

Founder


robert-horvitz_image

Robert Horvitz

yi-zhang_image

Yi Zhang

Stock Details


Company's stock symbol is NASDAQ:EPZM

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Epizyme

royalty-pharma_image

Royalty Pharma

Royalty Pharma investment in Post-IPO Equity - Epizyme

celgene_image

Celgene

Celgene investment in Post-IPO Equity - Epizyme

glaxosmithkline_image

GlaxoSmithKline

GlaxoSmithKline investment in Venture Round - Epizyme

leukemia-lymphoma-society_image

Leukemia & Lymphoma Society

Leukemia & Lymphoma Society investment in Venture Round - Epizyme

multiple-myeloma-research-foundation_image

Multiple Myeloma Research Foundation

Multiple Myeloma Research Foundation investment in Grant - Epizyme

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Epizyme

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Epizyme

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series B - Epizyme

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series B - Epizyme

Official Site Inspections

http://www.epizyme.com Semrush global rank: 7.1 M Semrush visits lastest month: 594

  • Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
  • IP address: 15.197.142.173
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Epizyme" on Search Engine

dfkcompany.com © 2022. All rights reserved